James Anthony Cannon - Net Worth and Insider Trading
James Anthony Cannon Net Worth
The estimated net worth of James Anthony Cannon is at least $4,020 dollars as of 2024-09-20. James Anthony Cannon is the Director of Alaunos Therapeutics Inc and owns about 1,467 shares of Alaunos Therapeutics Inc (TCRT) stock worth over $4,020. Details can be seen in James Anthony Cannon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Anthony Cannon has not made any transactions after 2009-12-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Anthony Cannon
James Anthony Cannon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Anthony Cannon owns 1 companies in total, including Alaunos Therapeutics Inc (TCRT) .
Click here to see the complete history of James Anthony Cannon’s form 4 insider trades.
Insider Ownership Summary of James Anthony Cannon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCRT | Alaunos Therapeutics Inc | 2009-12-09 | director |
James Anthony Cannon Latest Holdings Summary
James Anthony Cannon currently owns a total of 1 stock. James Anthony Cannon owns 1,467 shares of Alaunos Therapeutics Inc (TCRT) as of December 9, 2009, with a value of $4,020.
Latest Holdings of James Anthony Cannon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TCRT | Alaunos Therapeutics Inc | 2009-12-09 | 1,467 | 2.74 | 4,020 |
Holding Weightings of James Anthony Cannon
James Anthony Cannon Form 4 Trading Tracker
According to the SEC Form 4 filings, James Anthony Cannon has made a total of 0 transactions in Alaunos Therapeutics Inc (TCRT) over the past 5 years. The most-recent trade in Alaunos Therapeutics Inc is the acquisition of 1,167 shares on December 9, 2009, which cost James Anthony Cannon around $542,500.
Insider Trading History of James Anthony Cannon
- 1
James Anthony Cannon Trading Performance
GuruFocus tracks the stock performance after each of James Anthony Cannon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Anthony Cannon is 21.79%. GuruFocus also compares James Anthony Cannon's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Anthony Cannon within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Anthony Cannon's insider trading performs compared to the benchmark.
Performance of James Anthony Cannon
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.64 | | | | | |
| Relative Return to S&P 500(%) | -5.11 | | | | | |
James Anthony Cannon Ownership Network
James Anthony Cannon Owned Company Details
What does Alaunos Therapeutics Inc do?
Who are the key executives at Alaunos Therapeutics Inc?
James Anthony Cannon is the director of Alaunos Therapeutics Inc. Other key executives at Alaunos Therapeutics Inc include director & Chief Executive Officer Boyle Kevin S. Sr. , VP & Finance Michael Wong , and See Remarks Abhishek K Srivastava .
Alaunos Therapeutics Inc (TCRT) Insider Trades Summary
Over the past 18 months, James Anthony Cannon made no insider transaction in Alaunos Therapeutics Inc (TCRT). Other recent insider transactions involving Alaunos Therapeutics Inc (TCRT) include a net sale of 68,014 shares made by Boyle Kevin S. Sr. ,
In summary, during the past 3 months, insiders sold 0 shares of Alaunos Therapeutics Inc (TCRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 453 shares of Alaunos Therapeutics Inc (TCRT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 453 shares.
Alaunos Therapeutics Inc (TCRT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alaunos Therapeutics Inc Insider Transactions
James Anthony Cannon Mailing Address
Above is the net worth, insider trading, and ownership report for James Anthony Cannon. You might contact James Anthony Cannon via mailing address: Bbdo, 1285 Avenue Of The Americas, New York Ny 10019.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
